Amazing how much of an annual report is dedicated to remuneration. My strategy right now would be hire a CEO on 4-500k to manage costs and revamp retail products in terms of marketing and retaining margin and getting FDA approval for both Vivagel and Viraleze. Done right the business would be potentially cash positive in a relatively short period IMO. Ok so DEP is the potential bigger bucks?? Hopefully the upcoming results are positive and I would take the most likely candidate forward with a partner for a relatively higher up front and less ongoing just to keep the wolves from the door in terms of needing capital. If results in other areas are promising you can adjust the up front vs later milestones (but at least get some upfront). Over $2 million paid to Management for a $4 million revenue is pretty disgusting return. Screaming for a business model revue. As the business recovers hopefully the CEO can grow into the role or they expand with additional Exec? I don't think any of the current Management could possibly justify their positions right now. Of course the chair has watched on as it all unfolds. I still don't get the stubborn attitude to Vivagel and the FDA? MSB has reversed somewhat from the lows - I don't see much light for SPL until the changes are made.
SPL Price at posting:
14.5¢ Sentiment: Hold Disclosure: Held
